2014, Número 610
<< Anterior Siguiente >>
Rev Med Cos Cen 2014; 71 (610)
Hiperplasia suprarenal congénita de comienzo tardío
Callaú BA
Idioma: Español
Referencias bibliográficas: 12
Paginas: 371-374
Archivo PDF: 167.17 Kb.
RESUMEN
The late onset congenital
adrenal hyperplasia, also called
Nonclassic, has a much milder
clinical presentation than the
classic “Salt wasting form”,
and is a condition that may
go unnoticed or mistaken for
polycystic ovary syndrome.
The history of newborn
screening is not reliable to
rule out its presence and if
suspected, measurements
must be performed
(17-hydroxyprogesterone). The
treatment of this disease has
proven to be useful because
it improves the fertility of the
affected people but are not yet
duly filed regimes.
REFERENCIAS (EN ESTE ARTÍCULO)
Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. Clinical review 374 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA 56. J Clin Endocrinol Metab 1996;78:810-815.
Escobar-Morreale H, Sanchon R, San Millán J. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008; 93: 527-33.
Gardner, D & Shoback, D. (2012) Hipertensión endocrina. En D. Cooper, Endocrinología Básica y Clínica de Greenspan (9° Ed p 340). Mexico DF.
Kliegman R, Behrman R, Jenson H & Stanton B. (2008) Hiperplasia suprarrenal congénita y trastornos relacionados. Nelson Tratado de Pediatría (18° Ed pp 2360-2366). Madrid.
Melmed S, Polonsky K, Larsen P. & Kronenberg H. (2011). The Adrenal cortex. En G. Brent & T. Davies, Williams Textbook of Endocrinology (12° Ed pp 525-526) Philadelphia.
New M. Infertility and androgen excess in nonclassical 21-hydroxylase deficiency. Symposium on the ovary: regulation, dysfunction and treatment, Marco Island, FL. 1996: 195-8. 6.
Pombo M & Arjemí J (1997) Anomalías de la diferenciación sexual. En Audí L, Tratado de endocrinología Pediátrica. (2° Ed p 826) Madrid.
Sanchez A, Salvador E & Ramirez A. (2010) Hiperplasia suprarrenal congénita de inicio tardío y síndrome de ovarios poliquísticos. Igual fenotipo diferente origen y destino. Instituto Nacional de Perinatología Isidro Espinosa de los Reyes. Volumen 24, Número 4 pp 221-227.
Speiser P, Knochenhauer E, Dewailly D, Fruzzetti F, Marcondes J, Azziz R. A multicenter study of women with nonclassical congenital hyperplasia: relationship between genotype and phenotype. Mol Gen Metabol 2000; 71: 527-34.
Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2008; 349: 776-88.
White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
Zerah M, Ueshiba H, Wood E,Speiser PW, Crawford C, McDonald T, Pareira J, Gruen D, new MI. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. J Clin Endocrinol Metab 1990; 70: 1662-7.